Comparison of remission and EULAR good response rates in 1677 patients with rheumatoid arthritis receiving methotrexate, leflunomide or TNF-blocking agents:: Results from a longitudinal observational study

被引：0
|
作者：
Kvien, TK
Schrumpf, M
Mowinckel, P
Mikkelsen, K
Nordvág, B
Kaufmann, C
Rodevand, E
机构：
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Lillehammer Hosp Rheumat Dis, Dept Rheumatol, Lillehammer, France
[3] Univ Hosp No Norway, Dept Rheumatol, Tromso, Norway
[4] Buskerud Cent Hosp, Dept Rheumatol, Drammen, Norway
[5] St Olav Hosp, Dept Rheumatol, Trondheim, Norway
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [21] Adalimumab plus methotrexate is more effective than adalimumab alone in patients with rheumatoid arthritis (RA) - Results from a longitudinal observational study
    Schrumpf, M
    Rodevand, E
    Mikkelsen, K
    Kaufmann, C
    Didriksen, A
    Mowinckel, P
    Kvien, TK
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 184 - +
  • [22] Predictors of response to methotrexate treatment: Results from a longitudinal observational study of 876 patients with RA
    Lie, E.
    Heiberg, M. S.
    Nordvag, B. Y.
    Rodevand, E.
    Kaufmann, C.
    Mikkelsen, K.
    Kvien, T. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 342 - 342
  • [23] The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study
    Heiberg, M. S.
    Kaufmann, C.
    Rodevand, E.
    Mikkelsen, K.
    Koldingsnes, W.
    Mowinckel, P.
    Kvien, T. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (08) : 1038 - 1042
  • [24] Efficacy and safety of Kineret® in RA patients previously treated with TNF-blocking agents.: Results from KREATIVE (Kineret® Response Assessment Initiative)
    Langer, HE
    Missler-Karger, B
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 288 - 288
  • [25] Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study
    Li, Z.
    Hu, J.
    Bao, C.
    Li, X.
    Li, X.
    Xu, J.
    Spindler, A. J.
    Zhang, X.
    Xu, J.
    He, D.
    Li, Z.
    Wang, G.
    Yang, Y.
    Wu, H.
    Ji, F.
    Tao, H.
    Zhan, L.
    Bai, F.
    Rooney, T. P.
    Zerbini, C. A. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : 732 - 741
  • [26] Modifications in Lipid Levels Are Independent of Serum TNF-α in Rheumatoid Arthritis: Results of an Observational 24-Week Cohort Study Comparing Patients Receiving Etanercept Plus Methotrexate or Methotrexate as Monotherapy
    Alejandra Rodriguez-Jimenez, Norma
    Garcia-Gonzalez, Carlos E.
    Patricia Ayala-Lopez, Karina
    Trujillo-Hernandez, Benjamin
    Anita Aguilar-Chavez, Erika
    Daniel Rocha-Munoz, Alberto
    Clemente Vasquez-Jimenez, Jose
    Olivas-Flores, Eva
    Salazar-Paramo, Mario
    Guadalupe Corona-Sanchez, Esther
    Vazquez-Del Mercado, Monica
    Varon-Villalpando, Evangelina
    Cota-Sanchez, Adolfo
    Cardona-Munoz, Ernesto German
    Gamez-Nava, Jorge I.
    Gonzalez-Lopez, Laura
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [27] THERAPEUTIC CERTOLIZUMAB PEGOL DRUG LEVELS TO ACHIEVE GOOD EULAR RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE BIOLOGICS IN RHEUMATOID ARTHRITIS GENETICS AND GENOMICS STUDY SYNDICATE (BRAGGSS) COHORT
    Hum, Ryan M.
    Ho, Pauline
    Nair, Nisha
    Plant, Darren
    Morgan, Ann W.
    Isaacs, John D.
    Wilson, Anthony G.
    Hyrich, Kimme L.
    Barton, Anne
    RHEUMATOLOGY, 2022, 61 : I9 - I9
  • [28] PREDICTORS OF ACR/EULAR BOOLEAN AND SDAI REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS TREATED WITH ANTI-TNF: AN ANALYSIS FROM THE PROSPECTIVE, OBSERVATIONAL REGISTRY, BIOTRAC
    Haraoui, B.
    Sheriff, M.
    Khraishi, M.
    Starr, M.
    Kelsall, J.
    Baker, M.
    Arendse, R.
    Dixit, S.
    Bensen, W.
    Baer, P.
    Faraawi, R.
    Rampakakis, E.
    Sampalis, J. S.
    Otawa, S.
    Lehman, A.
    Nantel, F.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 265 - 265
  • [29] CAN CYCLOSPORINE-A ASSOCIATED TO METHOTREXATE MAINTAIN REMISSION INDUCED BY ANTI-TNF AGENTS IN RHEUMATOID ARTHRITIS PATIENTS? (CYNAR PILOT STUDY)
    Migliore, A.
    Bizzi, E.
    Massafra, U.
    Vacca, F.
    Martin, L. S. Martin
    Ferlito, C.
    Podesta, E.
    Granata, M.
    Lagana, B.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (03) : 783 - 790
  • [30] Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational Registry, BioTRAC
    Haraoui, Boulos
    Sheriff, Maqbool
    Khraishi, Majed
    Starr, Michael
    Kelsall, John
    Baker, Milton
    Arendse, Regan
    Dixit, Sanjay
    Bensen, William
    Baer, Philip
    Faraawi, Rafat
    Rampakakis, Emmanouil
    Sampalis, John
    Lehman, Allen
    Nantel, Francois
    Shawi, May
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1443 - 1444
12345